Impact of rtI233V mutation in hepatitis B virus polymerase protein and adefovir efficacy: Homology modeling and molecular docking studies

Adefovir is an adenosine analogue approved by the Food and Drug Administration for the treatment of chronic hepatitis B. Mutations occurring in the hepatitis B virus (HBV) reverse transcriptase (rt) domains are shown to confer resistance to antiviral drugs. The role of the rtI233V mutation and adefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Ashrafali Mohamed, Sharma, Om Prakash, Kumar, Muthuvel Suresh, Kannangai, Rajesh, Abraham, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2013
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569598/
https://www.ncbi.nlm.nih.gov/pubmed/23423477
http://dx.doi.org/10.6026/97320630009121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569598/
https://www.ncbi.nlm.nih.gov/pubmed/23423477
http://dx.doi.org/10.6026/97320630009121

Ejemplares similares